RaySearch Laboratories AB (publ) (LON: 0GRZ)
London
· Delayed Price · Currency is GBP · Price in SEK 234.27
+0.55 (0.24%)
At close: Jan 31, 2025
RaySearch Laboratories AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 1,169 | 1,022 | 843.65 | 641.67 | 651.61 | 741.58 | Upgrade
|
| Revenue Growth (YoY) | 18.45% | 21.16% | 31.48% | -1.53% | -12.13% | 18.23% | Upgrade
|
| Cost of Revenue | 104.5 | 106.58 | 94.99 | 50.4 | 43.37 | 72.37 | Upgrade
|
| Gross Profit | 1,065 | 915.58 | 748.66 | 591.28 | 608.24 | 669.22 | Upgrade
|
| Selling, General & Admin | 566.6 | 558.01 | 481.14 | 422.23 | 397.52 | 445.56 | Upgrade
|
| Research & Development | 266.72 | 237.74 | 238.77 | 233.44 | 185.04 | 174.67 | Upgrade
|
| Other Operating Expenses | -7.38 | -2.33 | -1.56 | -0.35 | - | - | Upgrade
|
| Operating Expenses | 825.94 | 793.42 | 718.35 | 655.32 | 582.56 | 620.23 | Upgrade
|
| Operating Income | 238.56 | 122.16 | 30.31 | -64.04 | 25.68 | 48.99 | Upgrade
|
| Interest Expense | -6.93 | -9.7 | -11.48 | -6.04 | -5.75 | -6.82 | Upgrade
|
| Interest & Investment Income | 4.9 | 4.9 | 1.11 | 0.71 | 2.74 | 1.26 | Upgrade
|
| Currency Exchange Gain (Loss) | -7.28 | -7.28 | 12.44 | 10.7 | -29.14 | 19.18 | Upgrade
|
| Pretax Income | 229.25 | 110.09 | 32.38 | -58.67 | -6.48 | 62.61 | Upgrade
|
| Income Tax Expense | 54.19 | 28.52 | 8.6 | -11.36 | 2.6 | 12.2 | Upgrade
|
| Net Income | 175.06 | 81.57 | 23.78 | -47.32 | -9.08 | 50.41 | Upgrade
|
| Net Income to Common | 175.06 | 81.57 | 23.78 | -47.32 | -9.08 | 50.41 | Upgrade
|
| Net Income Growth | 172.80% | 243.06% | - | - | - | -35.80% | Upgrade
|
| Shares Outstanding (Basic) | 34 | 34 | 34 | 34 | 34 | 34 | Upgrade
|
| Shares Outstanding (Diluted) | 34 | 34 | 34 | 34 | 34 | 34 | Upgrade
|
| Shares Change (YoY) | 0.32% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 5.11 | 2.38 | 0.69 | -1.38 | -0.26 | 1.47 | Upgrade
|
| EPS (Diluted) | 5.11 | 2.38 | 0.69 | -1.38 | -0.26 | 1.47 | Upgrade
|
| EPS Growth | 172.46% | 244.84% | - | - | - | -35.81% | Upgrade
|
| Free Cash Flow | 481.05 | 431.64 | 307.26 | 186.19 | 301.8 | 272.91 | Upgrade
|
| Free Cash Flow Per Share | 14.04 | 12.59 | 8.96 | 5.43 | 8.80 | 7.96 | Upgrade
|
| Dividend Per Share | 0.700 | 0.700 | - | - | - | - | Upgrade
|
| Gross Margin | 91.06% | 89.57% | 88.74% | 92.15% | 93.34% | 90.24% | Upgrade
|
| Operating Margin | 20.41% | 11.95% | 3.59% | -9.98% | 3.94% | 6.61% | Upgrade
|
| Profit Margin | 14.97% | 7.98% | 2.82% | -7.37% | -1.39% | 6.80% | Upgrade
|
| Free Cash Flow Margin | 41.15% | 42.23% | 36.42% | 29.02% | 46.32% | 36.80% | Upgrade
|
| EBITDA | 280.61 | 164.21 | 69.74 | -33.24 | 56.89 | 77.46 | Upgrade
|
| EBITDA Margin | 24.00% | 16.06% | 8.27% | -5.18% | 8.73% | 10.44% | Upgrade
|
| D&A For EBITDA | 42.05 | 42.05 | 39.43 | 30.8 | 31.21 | 28.47 | Upgrade
|
| EBIT | 238.56 | 122.16 | 30.31 | -64.04 | 25.68 | 48.99 | Upgrade
|
| EBIT Margin | 20.41% | 11.95% | 3.59% | -9.98% | 3.94% | 6.61% | Upgrade
|
| Effective Tax Rate | 23.64% | 25.90% | 26.55% | - | - | 19.48% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.